Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
Study Details
Study Description
Brief Summary
Syphilis infection is a major global health problem, leading to substantial morbidity among key populations in low- and middle-income countries (LMICs). Men who have sex with men (MSM) are disproportionately affected by syphilis worldwide. Rates of syphilis diagnoses have been increasing amongst MSM in many countries in the last decade. A growing evidence base supporting HIV self-testing shows that self-testing kits based on the same proposed clinical pathways are feasible and reliable. The proposed study will leverage this body of evidence and apply it to syphilis self-testing.
This is a pilot study conducted in Zimbabwe. It aims to collect initial data on the feasability of implementing syphilis self-testing to establish if a large scale-RCT of this approach would be appropriate and, if so, to inform the design of this trial.
The investigators will recruit 100 MSM in Harare to join the pilot program. Participants will be recruited through two methods: in-person at MSM community-based organizations that currently operate HIV self-testing programs and online through banner advertisements that advertise HIV self-testing.
Study Arms:
Arm 1: One arm of the pilot will receive a free syphilis self-test kit (Intervention Arm) Arm 2: One arm will receive standard free facility-based syphilis testing (Control Arm).
Intervention:
In the intervention arm the investigators will provide a treponemal rapid syphilis test kit to all participants in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Among participants in the control group, they will receive a list of local clinics that can provide free syphilis testing.
Data Collection:
For individuals in the intervention am the investigators will aim to obtain confirmation of test uptake. This will be done using either photographic confirmation sent via encrypted message on a smartphone, SMS message of a unique code or sending a unique five-digit code along with their test result to the study coordinator. The investigators will conduct cross-sectional surveys at baseline and six months later to assess sexual risk behaviours, HIV and syphilis testing experiences, and self-testing experiences. In addition to the survey data tool the investigators will conduct in-depth interviews with a small number of participants to gain additional data about their experience of syphilis self-testing.
The investigators will obtain information on linkage to care from routine clinic administrative records and by providing study participants with a unique code to be provided when attending at the facility.
Analysis:
The investigators will used mixed-methods to evaluate our pilot intervention including
The investigators will examine the proportion of individuals who undertake a syphilis test in the interventional and control arms; among those who receive a test, the proportion of individuals who receive appropriate post-testing services. The investigators will also collect qualitative data on attitudes to syphilis self-testing and quantitative data on syphilis prevalence to inform a subsequent clinical trial.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Routine Testing Among men in the control group, they will receive a list of local clinics that can provide free syphilis testing. |
Diagnostic Test: Access to Facility based Syphilis Testing
List of facilities where syphilis testing can be accessed
|
Experimental: Self-Testing In the intervention arm we will provide a treponemal rapid syphilis test kit to all individuals in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. |
Diagnostic Test: Access to Facility based Syphilis Testing
List of facilities where syphilis testing can be accessed
Diagnostic Test: Syphilis Self-Test
Rapid Treponemal Test kit
|
Outcome Measures
Primary Outcome Measures
- Syphilis Tests Undertaken [6 months]
The total number of participants undertaking a syphilis test
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Men who have sex with men
-
Able to consent
Exclusion Criteria:
- Unable to consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Harare City Council Health Facilities | Harare | NIL Return | Zimbabwe |
Sponsors and Collaborators
- London School of Hygiene and Tropical Medicine
- Biomedical Research and Training Institute, Zimbabwe
- Pangaea Zimbabwe Aids Trust
Investigators
None specified.Study Documents (Full-Text)
More Information
Publications
None provided.- 17848
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Routine Testing | Self-Testing |
---|---|---|
Arm/Group Description | Among men in the control group, they will receive a list of local clinics that can provide free syphilis testing. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed | In the intervention arm we will provide a treponemal rapid syphilis test kit to all individuals in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed Syphilis Self-Test: Rapid Treponemal Test kit |
Period Title: Overall Study | ||
STARTED | 50 | 50 |
COMPLETED | 50 | 50 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Routine Testing | Self-Testing | Total |
---|---|---|---|
Arm/Group Description | Among men in the control group, they will receive a list of local clinics that can provide free syphilis testing. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed | In the intervention arm we will provide a treponemal rapid syphilis test kit to all individuals in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed Syphilis Self-Test: Rapid Treponemal Test kit | Total of all reporting groups |
Overall Participants | 50 | 50 | 100 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
50
100%
|
50
100%
|
100
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Sex: Female, Male (Count of Participants) | |||
Female |
0
0%
|
0
0%
|
0
0%
|
Male |
50
100%
|
50
100%
|
100
100%
|
Ethnicity (NIH/OMB) (Count of Participants) | |||
Hispanic or Latino |
0
0%
|
0
0%
|
0
0%
|
Not Hispanic or Latino |
50
100%
|
50
100%
|
100
100%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
Region of Enrollment (participants) [Number] | |||
Zimbabwe |
50
100%
|
50
100%
|
100
100%
|
Outcome Measures
Title | Syphilis Tests Undertaken |
---|---|
Description | The total number of participants undertaking a syphilis test |
Time Frame | 6 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Routine Testing | Self-Testing |
---|---|---|
Arm/Group Description | Among men in the control group, they will receive a list of local clinics that can provide free syphilis testing. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed | In the intervention arm we will provide a treponemal rapid syphilis test kit to all individuals in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed Syphilis Self-Test: Rapid Treponemal Test kit |
Measure Participants | 50 | 50 |
Count of Participants [Participants] |
29
58%
|
37
74%
|
Adverse Events
Time Frame | 6 months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Routine Testing | Self-Testing | ||
Arm/Group Description | Among men in the control group, they will receive a list of local clinics that can provide free syphilis testing. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed | In the intervention arm we will provide a treponemal rapid syphilis test kit to all individuals in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Access to Facility based Syphilis Testing: List of facilities where syphilis testing can be accessed Syphilis Self-Test: Rapid Treponemal Test kit | ||
All Cause Mortality |
||||
Routine Testing | Self-Testing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) | 9/50 (18%) | ||
Serious Adverse Events |
||||
Routine Testing | Self-Testing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) | 0/50 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Routine Testing | Self-Testing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) | 0/50 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Michael Marks |
---|---|
Organization | LSHTM |
Phone | 020 7636 8636 |
michael.marks@lshtm.ac.uk |
- 17848